Core Viewpoint - A class action has been filed against POMDoctor, Ltd. for allegedly being involved in a "pump-and-dump" scheme that misled investors during the class period from October 9, 2025, to December 11, 2025 [1][2]. Group 1: Allegations and Company Performance - POMDoctor's share price increased from the IPO price of $4.00 to a peak of $6.09 without any fundamental news justifying the rise, indicating potential manipulation [2]. - On December 10, 2025, the share price plummeted approximately 91% to $0.50, and it has since continued to decline to around $0.40 [2]. - The complaint alleges that POMDoctor engaged in a stock promotion scheme using social media to spread misinformation and impersonate financial professionals [3]. Group 2: Shareholder Actions - Shareholders wishing to serve as lead plaintiffs must submit their papers to the court by April 7, 2026, to represent other class members in the litigation [4]. - Shareholders can choose to remain absent from the case and still be eligible for recovery [4]. Group 3: Legal Representation - Robbins LLP operates on a contingency fee basis, meaning shareholders incur no fees or expenses unless a recovery is achieved [5].
POM Class Action: POMDoctor Ltd. Stockholders with Large Losses Should Contact Robbins LLP for Information About Recovering Their Losses